Seizert Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-12,972
Closed -$1.92M 200
2020
Q3
$1.92M Buy
12,972
+2,628
+25% +$407K 0.13% 74
2020
Q2
$1.7M Buy
10,344
+3,576
+53% +$549K 0.12% 81
2020
Q1
$939K Sell
6,768
-958
-12% -$132K 0.07% 108
2019
Q4
$1.01M Sell
7,726
-870
-10% -$101K 0.05% 131
2019
Q3
$961K Buy
+8,596
New +$957K 0.05% 122
2015
Q4
Sell
-2,759
Closed -$231K 231
2015
Q3
$231K Sell
2,759
-4,750
-63% -$401K 0.01% 184
2015
Q2
$627K Sell
7,509
-414,486
-98% -$31.6M 0.02% 165
2015
Q1
$30.7M Sell
421,995
-240,331
-36% -$17.1M 0.77% 55
2014
Q4
$45.7M Sell
662,326
-31,716
-5% -$2.14M 0.97% 49
2014
Q3
$45M Buy
694,042
+6,393
+0.9% +$405K 0.9% 51
2014
Q2
$42.8M Buy
687,649
+110,626
+19% +$6.6M 0.85% 52
2014
Q1
$34M Sell
577,023
-11,972
-2% -$668K 0.79% 56
2013
Q4
$30M Buy
588,995
+66,264
+13% +$3.32M 0.71% 58
2013
Q3
$26.3M Sell
522,731
-71,895
-12% -$3.76M 0.72% 56
2013
Q2
$29.2M Buy
+594,626
New +$32.4M 0.79% 52

Other funds holding LLY

Seizert Capital Partners's LLY Position: Q4 2020 in Review

Seizert Capital Partners sold out of Eli Lilly (LLY) in Q4 2020, closing a stake of 12,972 shares — an estimated $1.92M sold.

Seizert Capital Partners first reported a position in LLY in Q2 2013 and held it in 15 quarters. The position peaked at $45.7M in Q4 2014. 1,886 funds tracked by Wall St. Rank hold LLY as of Q4 2020.

  • Seizert Capital Partners reported no remaining Eli Lilly position as of Q4 2020 after selling out during the quarter.
  • Seizert Capital Partners sold 12,972 Eli Lilly shares in Q4 2020, an estimated $1.92M.
  • Seizert Capital Partners first reported a position in Eli Lilly in Q2 2013 and held it in 15 quarters.
  • Seizert Capital Partners's Eli Lilly position peaked at $45.7M in Q4 2014.
  • 1,886 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2020.

Based on Seizert Capital Partners's 13F filing for Q4 2020, filed 8 Feb 2021.